RegeneRx Biopharmaceuticals's ticker is RGRX and the CUSIP is 75886X108. A total of 3 filers reported holding RegeneRx Biopharmaceuticals in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $10,000 | +11.1% | 22,300 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $9,000 | +28.6% | 22,300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $7,000 | +75.0% | 22,300 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $4,000 | +33.3% | 22,300 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $3,000 | 0.0% | 22,300 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $3,000 | -25.0% | 22,300 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $4,000 | -20.0% | 22,300 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $5,000 | +66.7% | 22,300 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $3,000 | -25.0% | 22,300 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $4,000 | 0.0% | 22,300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $4,000 | -20.0% | 22,300 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $5,000 | -50.0% | 22,300 | -63.2% | 0.00% | -50.0% |
Q4 2017 | $10,000 | -23.1% | 60,612 | +49.2% | 0.00% | -33.3% |
Q3 2017 | $13,000 | +18.2% | 40,612 | 0.0% | 0.01% | +20.0% |
Q2 2017 | $11,000 | -38.9% | 40,612 | -35.1% | 0.01% | -37.5% |
Q1 2017 | $18,000 | -10.0% | 62,537 | 0.0% | 0.01% | -11.1% |
Q4 2016 | $20,000 | -13.0% | 62,537 | 0.0% | 0.01% | -18.2% |
Q3 2016 | $23,000 | -20.7% | 62,537 | 0.0% | 0.01% | -26.7% |
Q2 2016 | $29,000 | -34.1% | 62,537 | 0.0% | 0.02% | -34.8% |
Q1 2016 | $44,000 | +57.1% | 62,537 | 0.0% | 0.02% | +64.3% |
Q4 2015 | $28,000 | +7.7% | 62,537 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $26,000 | +13.0% | 62,537 | 0.0% | 0.01% | +27.3% |
Q2 2015 | $23,000 | +43.8% | 62,537 | 0.0% | 0.01% | +37.5% |
Q1 2015 | $16,000 | +77.8% | 62,537 | 0.0% | 0.01% | +100.0% |
Q4 2014 | $9,000 | +12.5% | 62,537 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $8,000 | -33.3% | 62,537 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $12,000 | 0.0% | 62,537 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $12,000 | +300.0% | 62,537 | 0.0% | 0.01% | +200.0% |
Q4 2013 | $3,000 | -25.0% | 62,537 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $4,000 | -20.0% | 62,537 | 0.0% | 0.00% | -33.3% |
Q2 2013 | $5,000 | – | 62,537 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 22,300 | $3,000 | 0.00% |
Williams Jones Wealth Management, LLC. | 140,000 | $22,000 | 0.00% |